Compounds > hydralazine
Page last updated: 2024-10-28

hydralazine and Carcinoma, Epidermoid

hydralazine has been researched along with Carcinoma, Epidermoid in 8 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research Excerpts

ExcerptRelevanceReference
"Hydralazine (Hyd) is a vaso-active drug that significantly affects the nature of blood flow in tumors."1.28[Hydralazine-induced enhancement of hyperthermia treatment in vivo]. ( Akagi, K; Hasegawa, T; Oshima, T; Tanaka, Y, 1992)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kozin, SV1
Hasegawa, T2
Ha-Kawa, SK1
Akagi, K2
Tanaka, Y3
Ohshima, T1
Thomas, C2
Counsell, C2
Sansom, J1
Wood, P2
Stratford, I1
Adams, G1
Oshima, T1
Stone, HB1
Minchinton, AI1
Lemmon, M1
Menke, D1
Brown, JM2
Adams, GE1
Lemmon, MJ1
Trotter, MJ1
Acker, BD1
Chaplin, DJ1

Other Studies

8 other studies available for hydralazine and Carcinoma, Epidermoid

ArticleYear
Hydralazine at thermoradiotherapy: tumor size and blood flow effects.
    International journal of radiation oncology, biology, physics, 1994, Jun-15, Volume: 29, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Hydralazine; Hyperthermia, Induced; Ma

1994
[Effect of hydralazine on the blood flow of normal and tumor tissues in hyperthermia].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1993, Aug-25, Volume: 53, Issue:8

    Topics: Animals; Carcinoma, Squamous Cell; Hydralazine; Hyperthermia, Induced; Laser-Doppler Flowmetry; Male

1993
The perfluorocarbon emulsion PFOB: potential indicator of change in blood volume using fluorine-19 NMR spectroscopy.
    EXS, 1992, Volume: 61

    Topics: Animals; Blood Volume; Carcinoma, Squamous Cell; Contrast Media; Fluorocarbons; Hydralazine; Hydroca

1992
[Hydralazine-induced enhancement of hyperthermia treatment in vivo].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1992, Nov-25, Volume: 52, Issue:11

    Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Combined Modality Therapy; Hydralazine; Hypertherm

1992
Pharmacological modification of tumor blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:1

    Topics: Animals; Blood Pressure; Carcinoma, Squamous Cell; Female; Flavonoids; Hydralazine; Mice; Mice, Inbr

1992
Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
    Journal of the National Cancer Institute, 1992, Feb-05, Volume: 84, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Fluorine; Fluorocarbons; Hydralazine; Hydrocarbons, Brominated; M

1992
Hydralazine does not increase hypoxia in tumors growing in preirradiated tissue.
    International journal of radiation oncology, biology, physics, 1991, Volume: 21, Issue:6

    Topics: Animals; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Hypoxia; Drug Administration Schedule;

1991
Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration.
    International journal of radiation oncology, biology, physics, 1989, Volume: 17, Issue:4

    Topics: Animals; Carcinoma, Squamous Cell; Erythrocyte Indices; Female; Hydralazine; Male; Mice; Mice, Inbre

1989